Urothelial cancer drugs market analysis

Urothelial cancer drugs market is expected to grow at an estimated value of USD 8,478.77 billion by 2028 while gain market growth at a potential rate of 23.20% in the forecast period of 2022 to 2028. Increasing number of awareness among the patients and physicians regarding the benefits of urothelial cancer drugs which will further create lucrative opportunities for the growth of the market.